XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Nov. 30, 2021
Nov. 30, 2020
Cash (used) provided by operating activities:    
Net income $ 183,970 $ 231,774
Adjustments to reconcile net income to net cash (used) provided by operating activities:    
Depreciation and amortization 26,082 27,995
Amortization of financing costs 738 772
Non-cash operating lease expense 6,910 4,910
Provision for credit losses 292 3,445
Non-cash share-based compensation 28,349 20,654
Gain on sale of North America Personal Care business (513) 0
(Gain) loss on the sale or disposal of property and equipment (2,274) 75
Deferred income taxes and tax credits (8,721) (4,132)
Changes in operating capital:    
Receivables (139,292) (155,492)
Inventory (103,821) (121,629)
Prepaid expenses and other current assets (6,765) (2,915)
Other assets and liabilities, net (6,110) (6,617)
Accounts payable (30,549) 148,501
Accrued expenses and other current liabilities 29,198 95,612
Accrued income taxes 17,452 6,793
Net cash (used) provided by operating activities (5,054) 249,746
Cash provided (used) by investing activities:    
Capital and intangible asset expenditures (41,529) (19,423)
Proceeds from sale of North America Personal Care business 44,700 0
Proceeds from the sale of property and equipment 5,305 0
Net cash provided (used) by investing activities 8,476 (19,423)
Cash used by financing activities:    
Proceeds from line of credit 461,400 917,400
Repayment of line of credit (356,400) (811,400)
Repayment of long-term debt (1,900) (1,900)
Payment of financing costs 0 (3,796)
Proceeds from share issuances under share-based compensation plans 5,721 4,528
Payments for repurchases of common stock (113,019) (202,961)
Net cash used by financing activities (4,198) (98,129)
Net (decrease) increase in cash and cash equivalents (776) 132,194
Cash and cash equivalents, beginning balance 45,120 24,467
Cash and cash equivalents, ending balance 44,344 156,661
Supplemental non-cash investing activity:    
Capital expenditures included in accounts payable $ 8,140 $ 0